Talk to a public procurement expert
company logo

Licitaciones a BIOGEN SPAIN, S.L.

Detailed analysis of BIOGEN SPAIN, S.L. as an awardee: Over the last 6 months it has participated in 375 public procurement procedures, with a success rate of 100%. The average budget of won tenders amounts to 93.318,61 €, with an average discount of 0.12%. The total volume awarded reaches 24.351.711,15 €, distributed among 29 contracting entities. Its main sector is Equipamiento y artículos médicos, farmacéuticos y de higiene personal, representing 268% of its awards. The entity that has awarded it the most contracts is SERVICIO ANDALUZ DE SALUD, with 238 awards.

Tenders

375
Awarded: 374
In progress: 0
Unawarded: 0

Budgets

26.409.168 €
Awarded amount: 26.347.382 €
Minor contracts: 2.383.416 €
Estimated value: 31.341.730 €

Averages

93.319 €
Discount rate: 0,1 %
Number of bidders: 1,0
Number of lots: 1,0

Organizations

29
Successful bidders: 1
Minor contracts: 306

Top 5 Contracting organizations

LogoSERVICIO ANDALUZ DE SALUD238
LogoConsejería de Sanidad··>Servicio Madrileño de Salud··>Dirección General Asistencial··>Gerencia Asistencial de Hospitales··>Hospital Universitario Ramón y Cajal20
LogoConsejería de Sanidad··>Servicio Madrileño de Salud··>Dirección General Asistencial··>Gerencia Asistencial de Hospitales··>Hospital Universitario Príncipe de Asturias20
LogoConsejería de Sanidad··>Servicio Madrileño de Salud··>Dirección General Asistencial··>Gerencia Asistencial de Hospitales··>Hospital General Universitario Gregorio Marañón16
LogoConsejería de Sanidad··>Servicio Madrileño de Salud··>Dirección General Asistencial··>Gerencia Asistencial de Hospitales··>Hospital Universitario 12 de Octubre13

Top 5 Bidders

LogoBIOGEN SPAIN, S.L.375

Top 5 CPVs

🩺Equipamiento y artículos médicos, farmacéuticos y de higiene personal268
💊Productos farmacéuticos266
💊Medicamentos diversos33
🩺Equipamiento médico2
🩺Material médico fungible2

Top 5 Budgets

CONTRACT OBJECTBASE BUDGETDETAILS

CCA: +6.6I54IIF. CBAM 995/2020 BIOGEN/06. ACUERDO MARCO CON UNA ÚNICA EMPRESA, P...

2.403.846,15 € View more

6 -CBAM BIOGEN SPAIN- Acuerdo marco con una única empresa, por lotes, por el que...

2.335.182,86 € View more

CORDOBA 7º CBAM BIOGEN 995/2020( 2207/2020) PARA EL ACUERDO MARCO CON UNA ÚNICA ...

1.731.207,55 € View more

4-CBAM BIOGEN SPAIN- Acuerdo marco con una única empresa, por lotes, por el que ...

1.398.035,06 € View more

3-CBAM BIOGEN SPAIN- Acuerdo marco con una única empresa, por lotes, por el que ...

1.398.035,06 € View more

Latest tenders won by BIOGEN SPAIN, S.L. - Diciembre 2025

Be the first to know about all tenders to BIOGEN SPAIN, S.L. in the last 12 months.

CONTRACT OBJECTBASE BUDGETFILE NUMBERDETAILS

NATALIZUMAB 300MG/INYECTABLE IV

⏱️ Offer submission deadline: 9 dic 18:34

14.142,48 € CONTR20250000484767View more

NATALIZUMAB 300MG/INYECTABLE IV

⏱️ Offer submission deadline: 9 dic 18:33

14.142,48 € CONTR20250000484763View more

NATALIZUMAB 300MG/INYECTABLE IV

⏱️ Offer submission deadline: 9 dic 18:33

14.142,48 € CONTR20250000484762View more

NATALIZUMAB 300MG/INYECTABLE IV

⏱️ Offer submission deadline: 9 dic 18:31

14.142,48 € CONTR20250000484754View more

NATALIZUMAB 150MG/JERINGA PRECARGADA 1 ML

⏱️ Offer submission deadline: 9 dic 18:00

14.142,48 € CONTR20250000484966View more

Other Bidders

Explore More Related Content

🏛️

Contracting Organizations

Discover the public organizations this company has worked with and their main contracts.

View organizations
📍

Tenders by Location

Explore the tenders available in Spain where this company could participate.

View tenders in Spain
🏢

Specialization Sectors

Learn about the sectors where this company has more experience and success in tenders.

Explore sectors
📋

Frequent CPV Codes

Review the most used CPV codes in the tenders this company has won.

View CPV codes
⚔️

Direct Competition

Analyze other bidding companies in the same sector to understand the competitive landscape.

View competition
📈

Market Trends

Stay up to date with the latest trends in public procurement and emerging opportunities.

View trends